3rd North American Symposium on Skeletal Complications of Malignancy

Last Modified: November 4, 2001

Share article


Date: April 25-27, 2002
Location: Natcher Conference Center-National Institutes of Health

Sponsors: Paget Foundation, Penn State College of Medicine, National Cancer Institute

URL of Homepage: www.paget.org

Who should attend: Oncologists, Hematologists, Urologists, and anyone interested in the bone metastases issue of cancer

Topics: Skeletal complications associated with breast cancer, prostate cancer, multiple myeloma, and the bone marrow microenvironment

Fees: $150US

Continuing Education: Yes, up to 18 hours

Miscellaneous: Cotact Paget Foundation at 212-509-5335 for more information


News
Denosumab Better for Breast Cancer With Bone Metastases

Aug 15, 2012 - In women with advanced breast cancer and bone metastases, denosumab is better than zoledronic acid in preventing skeletal complications and improving health-related quality of life, according to a study published online Aug. 14 in Clinical Cancer Research.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More